Preparation of the Siemens KION anesthetic machine for patients susceptible to malignant hyperthermia.

نویسندگان

  • Guy C Petroz
  • Jerrold Lerman
چکیده

BACKGROUND Preparation of anesthetic machines for use with malignant hyperthermia-susceptible (MHS) patients requires that the machines be flushed with clean fresh gas. We investigated the washout of inhalational anesthetics from the KION anesthetic machine. METHODS In part 1, halothane was circulated through KION anesthetic machines for either 2 or 12 h using a test lung. The times to washout halothane (to 10 parts per million [ppm]) first, from the internal circuitry and second, from the ventilator-patient cassette (without the carbon dioxide absorber) were determined at 5 and 10 l/min fresh gas flow (FGF). In part 2, the rates of washout of halothane or isoflurane from either the KION or Ohmeda Excel 210 machines were compared. The effluent gases were analyzed using calibrated Datex Capnomac Ultima (Helsinki, Finland) and a Miran LB2 Portable Ambient Air Analyzer (Foxboro, Norwalk, CT). RESULTS Halothane was washed out of the internal circuitry of the KION within 5 min at 10 l/min FGF. Halothane was eliminated from the ventilator-patient cassette in 22 min at the same FGF. The times to reach 10 ppm concentration of halothane and isoflurane in the KION at 10 l/min FGF, 23 to 25 min, was four-fold greater than those in the Ohmeda Excel 210, 6 min. CONCLUSIONS To prepare the KION anesthetic machine for MHS patients, the machine without the carbon dioxide absorber must be flushed with 10 l/min FGF for at least 25 min to achieve 10 ppm anesthetic concentration. This FGF should be maintained throughout the anesthetic to avoid increases in anesthetic concentration in the FGF.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Activated charcoal adsorption of volatile anesthetic agents for anesthesia machine preparation of malignant hyperthermia susceptible patients.

To the editor: We would like to share recent advancements regarding the utilization of activated charcoal filters to adsorb volatile anesthetic agents (VAAs). Although activated charcoal has been known for many years to adsorb VAAs,1-3 it has only recently become commercially available and endorsed by the Malignant Hyperthermia Association of the United States (MHAUS).4 MHAUS has put forth upda...

متن کامل

Preparation of the Dräger Primus anesthetic machine for malignant hyperthermia-susceptible patients.

PURPOSE Preparation of anesthesia machines for patients who are susceptible to malignant hyperthermia includes flushing the machine with vapour-free fresh gas to washout residual anesthetic agents. To establish guidelines for the preparation of the Dräger Primus machine, we compared the washout profiles for isoflurane and sevoflurane in the Dräger Primus and Ohmeda Excel 210 anesthesia machines...

متن کامل

New device simplifies workstation preparation for malignant hyperthermia-susceptible patients.

To the Editor: I read with interest the review article by Kim and Nemergut entitled “Preparation of Modern Anesthesia Workstations for Malignant Hyperthermia-susceptible Patients.” The authors are to be congratulated on this comprehensive review describing the challenges to preparing a modern anesthesia machine for use with malignant hyperthermia (MH)-susceptible patients. Indeed, their review ...

متن کامل

Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practice.

Patients with malignant hyperthermia experience an exaggerated metabolic response when exposed to volatile anesthetic gases and succinylcholine. The minimum concentration of anesthetic gas needed to trigger a malignant hyperthermia crisis in humans is unknown and may remain so because of the inherent risks associated with studying the complex nature of this rare and lethal genetic disorder. The...

متن کامل

SUPRAVENTRICULAR TACHYCARDIA FOLLOWING SECOND INDUCTION OF ANESTHESIA IN A PATIENT DIAGNOSED AS MALIGNANT HYPERTHERMIA AFTER FIRST ANESTHETIC EXPOSURE: TERMINOLOGY REQUIRES A SECOND LOOK

A 17 year old male who underwent surgery for thoracic outlet syndrome developed a postoperative complication which was labelled and diagnosed as malignant hyperthermia in Kerman Medical Center. The temperature recorded was 43°C, PaC02 70 mmHg and serum potassium level was 7 mEq/L. The patient was hospitalized in the intensive care unit for 10 days. On discharge, the patient had aphasia and...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Anesthesiology

دوره 96 4  شماره 

صفحات  -

تاریخ انتشار 2002